A Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometric Assay for the Quantification of Fabry Disease Biomarker Globotriaosylceramide (GB3) in Fabry Model Mouse

Fabry disease is a rare lysosomal storage disorder resulting from the lack of α-Gal A gene activity. Globotriaosylceramide (GB3, ceramide trihexoside) is a novel endogenous biomarker which predicts the incidence of Fabry disease. At the early stage efficacy/biomarker study, a rapid method to determi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Seok-Ho, Park, Min-Ho, Byeon, Jin-Ju, Lee, Byeong ill, Park, Yuri, Ko, Ah-ra, Seong, Mi-ran, Lee, Soyeon, Kim, Mi Ra, Seo, Jinwook, Jung, Myung Eun, Jin, Dong-Kyu, Shin, Young G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027126/
https://www.ncbi.nlm.nih.gov/pubmed/29880732
http://dx.doi.org/10.3390/pharmaceutics10020069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027126/
https://www.ncbi.nlm.nih.gov/pubmed/29880732
http://dx.doi.org/10.3390/pharmaceutics10020069

Ejemplares similares